 |
|
|
| |
Pretransplant Sofosbuvir and Ribavirin to
Prevent Recurrence of HCV Infection After Liver Transplantation
|
| |
| |
Reported by Jules Levin
AASLD 2013 Nov 1-4 Wash DC
Michael P. Curry1, Xavier Forns2, Raymond Chung3, Norah Terrault4, Robert Brown Jr5, Jonathan M. Fenkel6, Fredric Gordon7, Jacqueline O'Leary8, Alexander Kuo9, Thomas Schiano10, Gregory Everson11, Eugene Schiff12, Alex Befeler13, John G. McHutchison14, William T. Symonds14, Jill Denning14, Lindsay McNair14, Sarah Arterburn14, Dilip Moonka15 Edward Gane16, Nezam Afdhal1
1Beth Israel Deaconess Medical Center, Boston, MA; 2The Liver Unit, Barcelona, Spain; 3Massachusetts General Hospital, Boston, MA; 4University of California, San Francisco, CA; 5Columbia University, New York, NY; 6Thomas Jefferson University Hospital, Philadelphia, PA; 7Lahey Clinic, Burlington, MA; 8Baylor University Medical Center,, Dallas, TX; 9University of California, San Diego, La Jolla, CA; 10Mount Sinai School of Medicine, New York, NY; 11University
of Colorado, Denver, CO; 12University of Miami, Miami, FL; 13St Louis University, St. Louis, MO; 14Gilead Sciences, Inc., Foster City, CA; 15Henry Ford Health System, Detroit, MI; 16Auckland City Hospital, Auckland, New Zealand
|
| |
|
|
|
|
|
